Boston Scientific Corp (BSX)
73.34
+0.08
(+0.10%)
USD |
NYSE |
Apr 26, 14:24
Boston Scientific Cash from Financing (Quarterly): 15.00M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.00M |
| September 30, 2023 | 16.00M |
| June 30, 2023 | 43.00M |
| March 31, 2023 | -69.00M |
| December 31, 2022 | 1.00M |
| September 30, 2022 | -199.00M |
| June 30, 2022 | -344.00M |
| March 31, 2022 | -6.00M |
| December 31, 2021 | -8.00M |
| September 30, 2021 | 6.00M |
| June 30, 2021 | 2.00M |
| March 31, 2021 | -95.00M |
| December 31, 2020 | -819.00M |
| September 30, 2020 | -249.00M |
| June 30, 2020 | 1.105B |
| March 31, 2020 | 256.00M |
| December 31, 2019 | -724.00M |
| September 30, 2019 | 1.314B |
| June 30, 2019 | 256.00M |
| March 31, 2019 | 2.127B |
| December 31, 2018 | 425.00M |
| September 30, 2018 | 151.00M |
| June 30, 2018 | 726.00M |
| March 31, 2018 | 130.00M |
| December 31, 2017 | -68.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -139.00M |
| June 30, 2017 | 332.00M |
| March 31, 2017 | -15.00M |
| December 31, 2016 | 28.00M |
| September 30, 2016 | 34.00M |
| June 30, 2016 | -217.00M |
| March 31, 2016 | -51.00M |
| December 31, 2015 | -237.00M |
| September 30, 2015 | 761.00M |
| June 30, 2015 | 846.00M |
| March 31, 2015 | -94.00M |
| December 31, 2014 | -14.00M |
| September 30, 2014 | 18.00M |
| June 30, 2014 | 6.00M |
| March 31, 2014 | -160.00M |
| December 31, 2013 | -265.00M |
| September 30, 2013 | -138.00M |
| June 30, 2013 | -107.00M |
| March 31, 2013 | -114.00M |
| December 31, 2012 | -262.00M |
| September 30, 2012 | -239.00M |
| June 30, 2012 | -131.00M |
| March 31, 2012 | -132.00M |
| December 31, 2011 | -308.00M |
| September 30, 2011 | -179.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-819.00M
Minimum
Dec 2020
1.314B
Maximum
Sep 2019
26.37M
Average
1.00M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Stryker Corp | -286.00M |
| Abbott Laboratories | -2.052B |
| Edwards Lifesciences Corp | -413.20M |
| Intuitive Surgical Inc | -46.70M |
| Axonics Inc | 0.578M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 957.00M |
| Cash from Investing (Quarterly) | -1.053B |
| Free Cash Flow | 1.703B |
| Free Cash Flow Per Share (Quarterly) | 0.4673 |
| Free Cash Flow to Equity (Quarterly) | 488.00M |
| Free Cash Flow to Firm (Quarterly) | 732.91M |
| Free Cash Flow Yield | 1.59% |